Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Opticon GmbH at a Glance
Opticon GmbH is a company based in Karlsruhe, Baden-Württemberg, specializing in optical measurement technology and image processing systems for medical technology. The company focuses on the development of high-quality optical inspection and measurement systems for quality control of medical devices and pharmaceutical products. Karlsruhe is considered a significant center for measurement technology and optics in Germany, not least due to its proximity to the renowned KIT (Karlsruhe Institute of Technology), which drives advanced research and development in these fields. This synergy between research and industry plays a central role in the innovation level of Opticon's products.
Services and Products
Opticon GmbH develops optical inspection systems, image processing solutions, and measurement technology systems that enable 100-percent control in the manufacturing of medical devices. The systems reliably detect surface defects, dimensional deviations, and contamination on implants, surgical instruments, and pharmaceutical packaging. A key component of these technologies is the use of high-resolution camera systems and powerful algorithms for image analysis, ensuring that every product meets strict regulatory requirements.
The main product areas include not only inspection systems but also integrated solutions for automating production processes. These systems are designed to seamlessly integrate into existing packaging and assembly lines and provide real-time quality monitoring. Additionally, Opticon develops customized software solutions that allow customers to effectively evaluate the collected data and optimize quality assurance in their production processes.
Regulatory Classification
The products of Opticon GmbH are subject to strict regulatory requirements applicable in the medical technology and pharmaceutical industries. The systems comply with the European Union regulations for medical devices (MDR) as well as FDA requirements in the USA. This necessitates continuous documentation and validation of the systems to ensure their performance and reliability. The company invests significantly in the training of its employees and quality assurance to ensure that all products meet the highest standards.
Location Karlsruhe / Baden-Württemberg
Karlsruhe is a technology city on the Rhine and is home to KIT, one of Germany's leading research universities for engineering and measurement technology. This proximity to academic institutions and other innovative companies provides Opticon GmbH with ideal conditions for the development and marketing of optical measurement technology systems for medical technology. Furthermore, the company benefits from the dynamic start-up scene in Karlsruhe, which enables rapid development of innovative ideas into marketable products.
Baden-Württemberg is not only a leading location for the automotive industry and mechanical engineering but also an emerging center for medical technology. The close cooperation between industry and scientific institutions fosters a culture of innovation that Opticon GmbH leverages to remain at the forefront of technologies for the healthcare sector.
Special Features of Opticon GmbH
A standout feature of Opticon GmbH is its strong focus on research and development. The company works closely with universities of applied sciences and research institutions to develop new technologies and processes that further enhance the efficiency and precision of quality assurance in medical technology. With an interdisciplinary team of engineers, programmers, and physicists, Opticon can quickly respond to market changes and offer customized solutions.
Additionally, Opticon places great value on sustainability and resource conservation. The developed systems aim to minimize waste and use resources efficiently in the production process. The company is committed to contributing to environmental protection in medical technology through innovative approaches in the future.
More medical technology companies: Medical Technology Overview | Medical Technology Karlsruhe | Medical Technology Baden-Württemberg
Frequently asked questions about Opticon GmbH
What does Opticon GmbH do?
Opticon GmbH is a company in the medical technology sector based in Karlsruhe. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is Opticon GmbH located?
Opticon GmbH is headquartered in Karlsruhe. More information can be found on the company's website.
In which area of medical technology is Opticon GmbH active?
Opticon GmbH is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
More Medical Technology in Karlsruhe
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.